Select Language

GFAP

GFAP Overview

English Name	Glial fibrillary acidic protein	Approved Drugs	1
Drugs in Clinical Trials	0	Target Synonym	Glial Fibrillary Acidic Protein，Intermediate Filament Protein，ALXDRD，FLJ45472
Highest Development Stage	Approved

English Name	Glial fibrillary acidic protein
Target Synonym	Glial Fibrillary Acidic Protein，Intermediate Filament Protein，ALXDRD，FLJ45472
Approved Drugs	1
Drugs in Clinical Trials	0
Highest Development Stage	Approved

GFAP Product List

Product Category
Protein (2)Antibody (1)
Product Status
Launched (3)
Species
Mouse (1)Human (1)Rabbit (1)
Tag
His Tag (2)- (1)
Conjugate
Unconjugated (3)

Cat. No.	Species	Host	Product Description
GFP-H5143	Human	E. coli	Human GFAP Protein, His Tag
GFP-M5148	Mouse	E. coli	Mouse GFAP Protein, His Tag
GFP-S453	Rabbit	-	Polyclonal GFAP Antibody, Rabbit IgG

Total: 3

GFAP Background

GFAP (Glial fibrillary acidic protein) is a monomeric intermediate filament protein fuond in mature astrocytes and other glial cells but is not found outside the CNS. Increased GFAP immunoreactivity (or astrocytic activation) is usually viewed as an index of gliosis or a relatively slow-developing correlate of neural damage.

GFAP Synonyms

Glial fibrillary acidic protein

Marketed Drug Information

English Name	Research Code	Highest Development Stage	Company	First Brand Name	First Approved Country	First Indication	First Approved Company	First Approved Date	Indication	Clinical Trial
Gastrodine		Approved	Kpc Pharmaceuticals Inc	曲络彤, 丹彤, 辛基宁, 天眩清	Mainland China	Vertigo; Brain Injuries, Traumatic; Headache; Neurasthenia	Kpc Pharmaceuticals Inc	2001-01-01	Brain Injuries, Traumatic; Delirium; Emergence Delirium; Headache; Neurasthenia; Vertigo	Details